Safety and Feasibility of Oral Rehydration Solution Prior to Endoscopic Retrograde Cholangiopancreatography

Takamitsu Sasaki^*, Daisuke Kato, Ryohei Sakamoto, Satoshi Shinya, Hironari Shiwaku, Kanefumi Yamashita, Ryo Nakashima, Yuichi Yamashita

Department of Gastroenterological Surgery, Fukuoka University School of Medicine, Fukuoka, Japan.

DOI: 10.4236/ss.2015.63015                

Abstract

Purpose: The safety of oral rehydration therapy before endoscopic screening with respect to vital signs and complications after the screening procedure was assessed in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP). Methods: A total of 107 patients scheduled for ERCP were assigned to either the intravenous drip injection (DIV) group during fasting (56 patients) or ORS group given oral rehydration solution (51 patients) prior to endoscopy. Vital signs after ERCP, including blood pressure and temperature, blood biochemical data and the incidence of post-ERCP complications were compared between the groups. Results: No cases of aspiration pneumonia were detected in either groups. Moreover, there were no statistically significant differences between the DIV group and ORS group in terms of the biochemical data and vital signs after ERCP. The intergroup difference in the development of pancreatitis after ERCP was 2.3% [95% CI: ?5.7, 10.3], which was not statistically significant. Conclusions: The safety of oral rehydration therapy was found to be equivalent to that of the customary practice of infusion as a method for managing hydration and replenishing electrolytes in patients receiving ERCP. Oral rehydration therapy may be easily utilized as rehydration therapy prior to endoscopic screening for ERCP and other procedures.

Keywords

Endoscopic Retrograde Cholangiopancreatography, Oral Rehydration Therapy, Oral Rehydration Solution, Post-ERCP Pancreatitis, Complication

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Masci, E., Toti, G., Mariani, A., Curioni, S., Lomazzi, A., Dinelli, M., Minoli, G., Crosta, C., Comin, U., Fertitta, A., Prada, A., Passoni, G.R. and Testoni, P.A. (2001) Complications of Diagnostic and Therapeutic ERCP: A Prospective Multicenter Study. American Journal of Gastroenterology, 96, 417-423. http://dx.doi.org/10.1111/j.1572-0241.2001.03594.x
[2]	Wang, P., Li, Z.S., Liu, F., Ren, X., Lu, N.H., Fan, Z.N., Huang, Q., Zhang, X., He, L.P., Sun, W.S., Zhao, Q., Shi, R.H., Tian, Z.B., Li, Y.Q., Li, W. and Zhi, F.C. (2009) Risk Factors for ERCP-Related Complications: A Prospective Multicenter Study. American Journal of Gastroenterology, 104, 31-40. http://dx.doi.org/10.1038/ajg.2008.5
[3]	Farthing, M.J. (1994) Oral Rehydration Therapy. Pharmacology Therapeutics, 64, 477-492. http://dx.doi.org/10.1016/0163-7258(94)90020-5
[4]	World Health Organization (2002) Oral Rehydration Salts (ORS): A New Reduced Osmolarity Formulation. World Health Organization, Geneva.
[5]	Centers for Disease Control and Prevention (2003) Managing Acute Gastroenteritis among Children: Oral Rehydration, Maintenance, and Nutritional Bherapy. MMWR Recomm Rep 52 (No. RR-16), 1-16.
[6]	Mauer, A.M., Dweck, H.S., Finberg, L., Holmes, F., Reynolds, J.W., Suskind, R.M., Woodruff, C.W. and Hellerstein, S. (1985) American Academy of Pediatrics Committee on Nutrition: Use of Oral Fluid Therapy and Posttreatment Feeding Following Enteritis in Children in a Developed Country. Pediatrics, 75, 358-361.
[7]	Goseki, N., Hiranuma, S., Yamazaki, S., Maruyama, M., Nakajima, K., Gen, T. and Shirataka, M. (2007) Oral Rehydration Solution for Providing Water and Electrolytes Following Laparoscopic Cholecystectomy and Recovery of Intestinal Function. Hepatogastroenterology, 54, 2276-2281.
[8]	McIntyre, J.W. (1998) Evolution of 20th Century Attitudes to Prophylaxis of Pulmonary Aspiration during Anaesthesia. Canadian Journal of Anesthesia, 45, 1024-1030. http://dx.doi.org/10.1007/BF03012312
[9]	American Society of Anesthesiologists Committee (2011) Practice Guidelines for Preoperative Fasting and the Use of Pharmacologic Agents to Reduce the Risk of Pulmonary Aspiration: Application to Healthy Patients Undergoing Elective Procedures: An Updated Report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology, 114, 495-511. http://dx.doi.org/10.1097/ALN.0b013e3181fcbfd9
[10]	Smith, I., Kranke, P., Murat, I., Smith, A., O’Sullivan, G., Soreide, E., Spies, C. and In’t Veld, B. (2011) European Society of Anaesthesiology. Perioperative Fasting in Adults and Children: Guidelines from the European Society of Anaesthesiology. European Journal of Anaesthesiology, 28, 556-569. http://dx.doi.org/10.1097/EJA.0b013e3283495ba1
[11]	S?reide, E., Eriksson, L.I., Hirlekar, G., Eriksson, H., Henneberg, S.W., Sandin, R. and Raeder, J., Task Force on Scandinavian Pre-Operative Fasting Guidelines, Clinical Practice Committee Scandinavian Society of Anaesthesiology and Intensive Care Medicine (2005) Pre-Operative Fasting Guidelines: An Update. Acta Anaesthesiologica Scandinavica, 49, 1041-1047.
[12]	Merchant, R., Chartrand, D., Dain, S., Dobson, J., Kurrek, M., LeDez, K., Morgan, P. and Shukla, R., Canadian Anesthesiologists’ Society (2012) Guidelines to the Practice of Anesthesia Revised Edition 2012. Canadian Journal of Anesthesia, 59, 63-102. http://dx.doi.org/10.1007/s12630-011-9609-0
[13]	Fearon, K.C., Ljungqvist, O., Von Meyenfeldt, M., Revhaug, A., Dejong, C.H., Lassen, K., Nygren, J., Hausel, J., Soop, M., Andersen, J. and Kehlet, H. (2005) Enhanced Recovery after Surgery: A Consensus Review of Clinical Care for Patients Undergoing Colonic Resection. Clinical Nutrition, 24, 466-477. http://dx.doi.org/10.1016/j.clnu.2005.02.002
[14]	Nygren, J., Thorell, A., Jacobsson, H., Larsson, S., Schnell, P.O., Hylén, L. and Ljungqvist, O. (1995) Preoperative Gastric Emptying Effects of Anxiety and Oral Carbohydrate Administration. Annals of Surgery, 222, 728-734. http://dx.doi.org/10.1097/00000658-199512000-00006
[15]	McCune, W.S., Shorb, P.E. and Moscovitz, H. (1968) Endoscopic Cannulation of the Ampulla of Vater: A Preliminary Report. Annals of Surgery, 167, 752-756. http://dx.doi.org/10.1097/00000658-196805000-00013
[16]	Freeman, M.L., Nelson, D.B., Sherman, S., Haber, G.B., Herman, M.E., Dorsher, P.J., Moore, J.P., Fennerty, M.B., Ryan, M.E., Shaw, M.J., Lande, J.D. and Pheley, A.M. (1996) Complications of Endoscopic Biliary Sphincterotomy. New England Journal of Medicine, 335, 909-919. http://dx.doi.org/10.1056/NEJM199609263351301
[17]	Christensen, M., Matzen, P., Schulze, S. and Rosenberg, J. (2004) Complications of ERCP: A Prospective Study. Gastrointestinal Endoscopy, 60, 721-731. http://dx.doi.org/10.1016/S0016-5107(04)02169-8
[18]	Freeman, M.L., DiSario, J.A., Nelson, D.B., Fennerty, M.B., Lee, J.G., Bjorkman, D.J., Overby, C.S., Aas, J., Ryan, M.E., Bochna, G.S., Shaw, M.J., Snady, H.W., Erickson, R.V., Moore, J.P. and Roel, J.P. (2001) Risk Factors for Post-ERCP Pancreatitis: A Prospective, Multicenter Study. Gastrointestinal Endoscopy, 54, 425-434. http://dx.doi.org/10.1067/mge.2001.117550
[19]	Loperfido, S., Angelini, G., Benedetti, G., Chilovi, F., Costan, F., De Berardinis, F., De Bernardin, M., Ederle, A., Fina, P. and Fratton, A. (1998) Major Early Complications from Diagnostic and Therapeutic ERCP: A Prospective Multicenter Study. Gastrointestinal Endoscopy, 48, 1-10. http://dx.doi.org/10.1016/S0016-5107(98)70121-X
[20]	Masci, E., Mariani, A., Curioni, S. and Testoni, P.A. (2003) Risk Factors for Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography: A Meta-Analysis. Endoscopy, 35, 830-834. http://dx.doi.org/10.1055/s-2003-42614
[21]	Cavallini, G., Tittobello, A., Frulloni, L., Masci, E., Mariana, A. and Di Francesco, V., Gabexate in Digestive Endoscopy—Italian Group (1996) Gabexate for the Prevention of Pancreatic Damage Related to Endoscopic Retrograde Cholangiopancreatography. New England Journal of Medicine, 335, 919-923. http://dx.doi.org/10.1056/NEJM199609263351302
[22]	Masci, E. and Mariani, A. (2003) Short-Term Prophylactic Prevention of Post-ERCP Pancreatitis. Gastrointestinal Endoscopy, 58, 816. http://dx.doi.org/10.1016/S0016-5107(03)02000-5
[23]	Devière, J., Le Moine, O., Van Laethem, J.L., Eisendrath, P., Ghilain, A., Severs, N. and Cohard, M. (2001) Interleukin 10 Reduces the Incidence of Pancreatitis after Therapeutic Endoscopic Retrograde Cholangiopancreatography. Gastroenterology, 120, 498-505. http://dx.doi.org/10.1053/gast.2001.21172
[24]	Dumot, J.A., Conwell, D.L., Zuccaro Jr., G., Vargo, J.J., Shay, S.S., Easley, K.A. and Ponsky, J.L. (2001) A Randomized, Double Blind Study of Interleukin 10 for the Prevention of ERCP-Induced Pancreatitis. American Journal of Gastroenterology, 96, 2098-2102. http://dx.doi.org/10.1111/j.1572-0241.2001.04092.x
[25]	Murray, B., Carter, R., Imrie, C., Evans, S. and O’Suilleabhain, C. (2003) Diclofenac Reduces the Incidence of Acute Pancreatitis after Endoscopic Retrograde Cholangiopancreatography. Gastroenterology, 124, 1786-1791. http://dx.doi.org/10.1016/S0016-5085(03)00384-6
[26]	Singh, P., Das, A., Isenberg, G., Wong, R.C., Sivak Jr., M.V., Agrawal, D. and Chak, A. (2004) Does Prophylactic Pancreatic Stent Placement Reduce the Risk of Post-ERCP Acute Pancreatitis? A Meta-Analysis of Controlled Trials. Gastrointestinal Endoscopy, 60, 544-550. http://dx.doi.org/10.1016/S0016-5107(04)02013-9
[27]	Freeman, M.L., Overby, C. and Qi, D. (2004) Pancreatic Stent Insertion: Consequences of Failure and Results of a Modified Technique to Maximize Success. Gastrointestinal Endoscopy, 59, 8-14. http://dx.doi.org/10.1016/S0016-5107(03)02530-6